BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Teva
Citi
Medtronic
Covington
Baxter
Deloitte
Julphar
Accenture
AstraZeneca

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017518

« Back to Dashboard

NDA 017518 describes YTTERBIUM YB 169 DTPA, which is a drug marketed by 3M and is included in one NDA. Additional details are available on the YTTERBIUM YB 169 DTPA profile page.

The generic ingredient in YTTERBIUM YB 169 DTPA is pentetate calcium trisodium yb-169. There is one drug master file entry for this compound. Additional details are available on the pentetate calcium trisodium yb-169 profile page.
Summary for 017518
Tradename:YTTERBIUM YB 169 DTPA
Applicant:3m
Ingredient:pentetate calcium trisodium yb-169
Patents:0

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength2mCi/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Dow
Mallinckrodt
Argus Health
Baxter
Teva
Boehringer Ingelheim
Daiichi Sankyo
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot